Aurinia Pharmaceuticals Inc. (AUPH)
USD 9.1
(-4.71%)
USD 9.1
(-4.71%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 175.51 Million | 134.03 Million | 45.6 Million | 50.11 Million | 318 Thousand | 463 Thousand |
| Cost of Revenue | 14.14 Million | 5.66 Million | 1.09 Million | 50.32 Million | 52.86 Million | 41.38 Million |
| Gross Profit | 161.36 Million | 128.36 Million | 44.51 Million | -209 Thousand | -52.54 Million | -40.91 Million |
| Operating Expenses | 253.05 Million | 239.83 Million | 225.24 Million | 147.59 Million | 76.56 Million | 56.62 Million |
| Selling, General and Administrative Expenses | 195.03 Million | 196.37 Million | 171.43 Million | 95.98 Million | 22.15 Million | 13.67 Million |
| Research and Development Expenses | 49.64 Million | 44.98 Million | 51.13 Million | 50.32 Million | 52.86 Million | 41.38 Million |
| Other Expenses | 8.37 Million | -1.52 Million | 2.67 Million | 1.28 Million | 1.54 Million | 2.06 Million |
| Cost and Expenses | 267.2 Million | 245.5 Million | 226.34 Million | 147.59 Million | 76.56 Million | 56.62 Million |
| Operating Income | -91.69 Million | -111.47 Million | -180.73 Million | -104.29 Million | -82.53 Million | -56.15 Million |
| Interest Expense | 2.77 Million | 5.11 Million | - | - | 39 Thousand | 2.23 Million |
| Income Tax Expense | 551 Thousand | 1.82 Million | 760 Thousand | -94 Thousand | 144 Thousand | 73 Thousand |
| Earnings before Tax | -77.46 Million | -106.35 Million | -180.2 Million | -102.77 Million | -123.7 Million | -64.04 Million |
| Net Income | -78.02 Million | -108.18 Million | -180.96 Million | -102.68 Million | -123.84 Million | -64.12 Million |
| Earnings Per Share Basic | -0.54 | -0.76 | -1.40 | -0.87 | -1.33 | -0.76 |
| Earnings Per Share Diluted | -0.54 | -0.76 | -1.40 | -0.87 | -1.33 | -0.76 |
| Weighted Average Shares Outstanding | 143.23 Million | 141.91 Million | 129.36 Million | 118.47 Million | 93.02 Million | 84.78 Million |
| Weighted Average Shares Outstanding (Diluted) | 143.23 Million | 141.91 Million | 129.36 Million | 118.47 Million | 93.02 Million | 84.78 Million |
| Gross Margin | 0.92 | 0.96 | 0.98 | -0.00 | -165.25 | -88.38 |
| EBIT Margin | -0.36 | -0.83 | -3.92 | -1.92 | -254.69 | -96.41 |
| Profit Margin | -0.44 | -0.81 | -3.97 | -2.05 | -389.45 | -138.49 |
| EBITDA | -63.04 Million | -103.64 Million | -177.44 Million | -102.91 Million | -89.77 Million | -53.92 Million |
| Earnings Before Tax Margin | -0.52 | -0.83 | -3.96 | -2.08 | -259.56 | -121.29 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 57.19 Million | 50.3 Million | 45.09 Million | 175.51 Million | 54.51 Million | 41.49 Million |
| Cost of Revenue | 8.9 Million | 7.75 Million | 5.39 Million | 14.14 Million | 6.76 Million | 1.56 Million |
| Gross Profit | 48.28 Million | 42.55 Million | 39.7 Million | 161.36 Million | 47.74 Million | 39.93 Million |
| Operating Expenses | 49.01 Million | 53.24 Million | 60.3 Million | 244.67 Million | 64 Million | 56.1 Million |
| Selling, General and Administrative Expenses | 44.93 Million | 47.69 Million | 50.07 Million | - | 47.75 Million | 47.08 Million |
| Research and Development Expenses | 4.08 Million | 5.55 Million | 10.22 Million | - | 13.6 Million | 12.65 Million |
| Other Expenses | 782 Thousand | 2.55 Million | 9.07 Million | 8.37 Million | 2.64 Million | - |
| Cost and Expenses | 57.92 Million | 60.99 Million | 65.69 Million | 258.82 Million | 70.77 Million | 57.66 Million |
| Operating Income | -731 Thousand | -10.69 Million | -20.6 Million | -83.31 Million | -16.26 Million | -16.17 Million |
| Interest Expense | 1.19 Million | 1.28 Million | 1.31 Million | 2.77 Million | 1.4 Million | 65 Thousand |
| Income Tax Expense | 756 Thousand | 739 Thousand | 459 Thousand | 551 Thousand | 298 Thousand | -642 Thousand |
| Earnings before Tax | 1.47 Million | -10.01 Million | -26.41 Million | -77.46 Million | -13.14 Million | -12.13 Million |
| Net Income | 722 Thousand | -10.74 Million | -26.87 Million | -78.02 Million | -13.44 Million | -11.49 Million |
| Earnings Per Share Basic | 0.01 | -0.07 | -0.19 | - | -0.09 | -0.08 |
| Earnings Per Share Diluted | 0.01 | -0.07 | -0.19 | - | -0.09 | -0.08 |
| Weighted Average Shares Outstanding | 143.32 Million | 144.01 Million | 143.83 Million | 143.23 Million | 142.84 Million | 142.77 Million |
| Weighted Average Shares Outstanding (Diluted) | 144.11 Million | 144.01 Million | 143.83 Million | 143.23 Million | 142.84 Million | 142.77 Million |
| Gross Margin | 0.84 | 0.85 | 0.88 | 0.92 | 0.88 | 0.96 |
| EBIT Margin | 0.07 | -0.12 | -0.35 | - | -0.12 | -0.27 |
| Profit Margin | 0.01 | -0.21 | -0.60 | -0.44 | -0.25 | -0.28 |
| EBITDA | 4.11 Million | -5.84 Million | -15.65 Million | - | -6.48 Million | -11.35 Million |
| Earnings Before Tax Margin | -0.01 | -0.21 | -0.46 | -0.47 | -0.30 | -0.39 |
4323
CAZ
084110
CNLTP
600455
0091